Pagibaximab

Tax included
Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis.
MedChemExpress 
HY-P99309

Data sheet

Size
Multiple sizes
Reactivity
Bacterial
Application
COVID-19-immunoregulation
CAS
595566-61-3